CRTX — CRISM' Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00- £4.41m
- £1.02m
Annual balance sheet for CRISM' Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.398 | 2.79 | 6.68 | 3.48 | 4.38 |
| Net Total Receivables | 0.032 | 0.005 | 0.109 | 0 | — |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 0.885 | 3.15 | 6.79 | 3.55 | 4.79 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 27.4 | 24 | 0 | — | — |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 28.3 | 32.4 | 31.2 | 28.7 | 4.79 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.965 | 0.913 | 0.968 | 0.745 | 0.662 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1.13 | 1.05 | 1.13 | 0.921 | 0.662 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 27.1 | 31.4 | 30.1 | 27.8 | 4.12 |
| Total Liabilities & Shareholders' Equity | 28.3 | 32.4 | 31.2 | 28.7 | 4.79 |
| Total Common Shares Outstanding |